CN100391511C

CN100391511C - Peach kernel macrostem onion powder

Info

Publication number: CN100391511C
Application number: CNB2005100419209A
Authority: CN
Inventors: 韩勇
Original assignee: Individual
Current assignee: Individual
Priority date: 2005-04-07
Filing date: 2005-04-07
Publication date: 2008-06-04
Anticipated expiration: 2025-04-07
Also published as: CN1843451A

Abstract

The present invention relates to an oral taking health-care product for adjuvant therapy of alopecia. The present invention comprises ingredients and weight percentage thereof as follows: 9% to 32% of peach seeds, 9% to 32% of field thistles, 10% to 32% of macrostem onions, 6% to 30% of dahurian angelica, 6% to 30% of platycodon roots and 9% to 32% of apricot kernels. The present invention solves the technical problems of poor therapeutic effect, no individuation therapy and adverse reaction existing in products for treating the alopecia in background art.

Description

A kind of medicine for the treatment of the alopecia of qi stagnation blood stasis type

One, technical field

The present invention relates to a kind of health product, especially a kind of Orally taken health article that is used for the auxiliary treatment alopecia.

Two, background technology

Since the quickening of modern life rhythm, the sharp increase of operating pressure, and various hair illness such as alopecia have brought increasing puzzlement for modern's life.The product for the treatment of alopecia in the market mostly is cosmetics, care appliance, and wherein Dai Biao product is the refreshing comb of ZHANGGUANG 101, newborn black pigment used by women in ancient times to paint their eyebrows hair growth promoting, and all there is following shortcoming in this series products:

1, therapeutic effect is poor.Because above two series products all are to be coated with by human external to touch or the mode of part massage is treated alopecia, can not enter human body, can not fundamentally improve the natural on-off cycles of hair growth environment, therefore can only cure the symptoms, not the disease, control outer do not control in, so therapeutic effect is very little.

2, no personalized treatment.More than two series products can not carry out meticulous dialectical allotment, can not accomplish to shoot the arrow at the target at dissimilar patients.

3, untoward reaction is arranged.Untoward reaction such as can occur swelling and ache when using on the hair of allergic skin body constitution.

Three, summary of the invention

The product therapeutic effect that the invention solves the treatment alopecia in the background technology is poor, do not have personalized treatment and the technical problem of untoward reaction is arranged.

Technical scheme of the present invention is: the present invention is a kind of medicine for the treatment of the alopecia of qi stagnation blood stasis type, and its special character is: the percentage by weight component of the medicine of described treatment qi stagnation blood stasis type alopecia is Semen Persicae 9～32%, Herba Cirsii 9～32%, Bulbus Allii Macrostemonis 10～32%, the Radix Angelicae Dahuricae 6～30%, Radix Platycodonis 6～30%, Semen Armeniacae Amarum 9～32%.

The present invention faces the card experience according to the traditional Chinese medical science several thousand, and find in the medical practice of the clinical experience of two more than ten years and treatment alopecia, the people is an integral body, hair is a part of human body, if the human physiological functions imbalance, the natural on-off cycles of hair growth environment is destroyed, and then hair comes off in a large number, hair is sparse, even bald.Therefore the present invention is according to the basic theories of the traditional Chinese medical science " organic conception ", " treatment must aim at the pathogenesis of disease ", " dialectical opinion is controlled ", simultaneously according to the function of human body of putting down in writing in Compendium of Material Medica, Shennong's Herbal, " Treatise on Dietetic Therapy " of improvement that has, the integration of edible and medicinal herbs product that can eat again, the file of the integration of edible and medicinal herbs of announcing according to health ministry, develop this health food, so the present invention has the following advantages:

1, integration of edible and medicinal herbs, therapeutic effect is good.The present invention looses in conjunction with hair growth accelerating to use together, by the oral function of human body of adjusting, improves the natural on-off cycles of hair growth environment, but treating both the principal and secondary aspects of a disease.

2, can carry out personalized treatment.The present invention can carry out meticulous dialectical allotment according to patient's different body constitution, symptom, looses in conjunction with hair growth accelerating and uses together, accomplishes personalized treatment; The present invention is that to be mainly used in the scalp of caused by energy stagnation and blood stasis purple dark, and if pain is acupuncture, itch if the ant row, the time see headache, chest pain, general pain, menoxenia, various alopecia qi depressions to blood stasis such as traumatic injury lay particular stress on the auxiliary treatment of disease type.

3, had no side effect, filled up the blank of the health food of treatment alopecia.

Four, the specific embodiment

It is monarch drug that the present invention selects Semen Persicae, Herba Cirsii blood circulation promoting and blood stasis dispelling; The Bulbus Allii Macrostemonis merit of loosing joint, regulating the flow of vital energy with the blood circulation promoting and blood stasis dispelling that strengthens monarch drug of activating yang is a ministerial drug; The Radix Angelicae Dahuricae, Radix Platycodonis, Semen Armeniacae Amarum priming are up, make for assistant altogether.

The consumption of component of the present invention is also groped to sum up to draw through the inventor in a large number, and each amounts of components is for all to have good efficacy in following weight percentage ranges:

Percentage by weight consumption of the present invention is: Semen Persicae 9～32%, Herba Cirsii 9～32%, Bulbus Allii Macrostemonis 10～32%, the Radix Angelicae Dahuricae 6～30%, Radix Platycodonis 6～30%, Semen Armeniacae Amarum 9～32%.

Below be concrete proportioning example of the present invention (is unit with the percentage by weight)

Production technology of the present invention following (production technology with health promoting beverage is an example):

1) each raw material is taken by weighing by proportioning;

2) raw material pulverizing that proportioning is good, sieve;

3) hybrid packed the getting final product of raw material after will sieving.

Clinical comparison experimental result of the present invention is as follows:

Lay particular stress on disease type alopecia patient at the diffusing primary symptom qi depression to blood stasis of hair growth accelerating, with every group 50 example, carry out 2 groups of treatments, curative effect is as follows:

Example one, matched group: the treatment of loosing of the oral hair growth accelerating of patient, every day twice, each 5 grams, with 4 weeks be a course of treatment, after 6 courses of treatment, 13 examples of fully recovering, 31 examples, invalid 6 examples take a turn for the better.

Example two, the treatment group: patient's oral hair growth accelerating of while looses and component is the medicine of the treatment qi stagnation blood stasis type alopecia of Semen Persicae, Herba Cirsii, Bulbus Allii Macrostemonis, the Radix Angelicae Dahuricae, Radix Platycodonis, Semen Armeniacae Amarum, twice of every day, each hair growth accelerating looses and the medicine of treatment qi stagnation blood stasis type alopecia respectively 5 restrains, with 4 weeks be a course of treatment, after 6 courses of treatment, 29 examples of fully recovering, improvement 16 examples, invalid 5 examples.

The above hair growth accelerating looses and is disclosed Chinese patent medicine preparation in the application for a patent for invention prospectus of publication number CN1504210A, and it is Rhizoma Atractylodis 1%-20% that its percentage by weight is formed; Rhizoma Atractylodis Macrocephalae (parched) 1%-12%; Radix Codonopsis 3%-30%; Radix Angelicae Sinensis 2%-27%; Rhizoma Chuanxiong 1%-18%; Radix Bupleuri 3%-25%; Radix Astragali 1%-20%; Radix Polygoni Multiflori Preparata 0.5%-10%; Clear Rhizoma Pinelliae Preparata 0.5%-2%; Polyporus 1%-10%; Poria 0.5%-10%; Semen Plantaginis 0.5%10%; Rhizoma Alismatis 0.5%10%; Semen Coicis 3%-30%; Flos Carthami 3%-30%; Radix Saposhnikoviae 0.1%-10%; Radix Paeoniae Rubra 3%-30%; Radix Salviae Miltiorrhizae 3%-30%; Semen Persicae 3%-30%; Pericarpium Citri Reticulatae 5%-30%; Fructus Aurantii 1%-10%; Herba Pogostemonis 3%-30%; Herba Eupatorii 3%30%; Herba Lycopi 3%-30%; Rhizoma Corydalis 3%-30%; Pericarpium Citri Reticulatae Viride 1%-30%; Cortex Magnoliae Officinalis 0.5%-20%; Radix Angelicae Dahuricae 1%-10%; Radix Platycodonis 3%30%.

Claims

1. medicine for the treatment of the alopecia of qi stagnation blood stasis type, it is characterized in that: the percentage by weight of its component is Semen Persicae 9～32%, Herba Cirsii 9～32%, Bulbus Allii Macrostemonis 10～32%, the Radix Angelicae Dahuricae 6～30%, Radix Platycodonis 6～30%, Semen Armeniacae Amarum 9～32%.